Al-Ghonaim Mohammed, Manns Braden J, Hirsch David J, Gao Zhiwei, Tonelli Marcello
Department of Medicine, University of Alberta, Edmonton, Canada.
Clin J Am Soc Nephrol. 2008 Mar;3(2):387-91. doi: 10.2215/CJN.03000707. Epub 2008 Jan 30.
Access blood flow (Qa) measurement is a potentially important determinant of systemic hemodynamics in hemodialysis patients. High Qa may contribute to left ventricular dilation and high output heart failure. On the other hand, low Qa might lead to underdialysis, which is associated with adverse outcomes.
In this retrospective study of incident chronic hemodialysis patients treated in three Canadian cities (Edmonton, Calgary, and Halifax), the hypothesis that extremes of Qa(low or high) would be associated with increased mortality was tested. The distribution of Qa was not Gaussian, and therefore Qa was log-transformed in analyses that treated it as a continuous variable. Qa was classified into categories defined by cutpoints of 500, 1000, 1500, and 2000 ml/min. Univariate and multivariate Cox proportional hazard models were performed to examine the relation between Qa and all-cause mortality. Patients were followed from the date of Qa measurement until death; follow-up was discontinued at loss to follow-up, kidney transplantation, or end of study.
Of 820 participants, those with lower levels of Qa tended to be older and to have more comorbidities. During the median follow-up period of 28 mo, 206 (25.1%) participants died and 101 (12.3%) patients received a kidney transplant. When only baseline measures of Qa were considered, there was significant association between Qa and mortality [hazard ratio (HR) per unit increase in logQa 0.81, 95% confidence interval (CI) 0.67, 0.97; adjusted HR per unit increase in logQa 0.90, 95% CI 0.72, 1.11]. The adjusted risk of mortality was similar between the different categories of baseline Qa before and after adjustment for demographic characteristics, comorbidity, and access type. In analyses that included all Qa measurements per patient as a time-varying covariate, the adjusted association between Qa and death remained nonsignificant, with no evidence of increased mortality at higher Qa (HR per unit increase in logQa 0.82, 95% CI 0.67, 1.01, P = 0.066).
The findings of this study do not suggest an increased risk of death at higher levels of Qa, Further studies would be needed to confirm an increased risk of death at lower Qa.
通路血流量(Qa)测量是血液透析患者全身血流动力学的一个潜在重要决定因素。高Qa可能导致左心室扩张和高输出量心力衰竭。另一方面,低Qa可能导致透析不充分,这与不良预后相关。
在这项对加拿大三个城市(埃德蒙顿、卡尔加里和哈利法克斯)初治慢性血液透析患者的回顾性研究中,检验了Qa极端值(低或高)与死亡率增加相关的假设。Qa的分布不是高斯分布,因此在将其作为连续变量进行分析时,对Qa进行了对数转换。Qa根据500、1000、1500和2000ml/分钟的切点分为不同类别。采用单因素和多因素Cox比例风险模型来检验Qa与全因死亡率之间的关系。从测量Qa之日起对患者进行随访直至死亡;随访在失访、肾移植或研究结束时终止。
820名参与者中,Qa水平较低者往往年龄较大且合并症较多。在28个月的中位随访期内,206名(25.1%)参与者死亡,101名(12.3%)患者接受了肾移植。仅考虑Qa的基线测量时,Qa与死亡率之间存在显著关联[logQa每增加一个单位的风险比(HR)为0.81,95%置信区间(CI)为0.67,0.97;logQa每增加一个单位的校正HR为0.90,95%CI为0.72,1.11]。在对人口统计学特征、合并症和通路类型进行调整前后,不同基线Qa类别的校正死亡风险相似。在将每位患者所有的Qa测量值作为时变协变量的分析中,Qa与死亡之间的校正关联仍然不显著,没有证据表明较高Qa时死亡率增加(logQa每增加一个单位的HR为0.82,95%CI为0.67,1.01,P = 0.066)。
本研究结果并不表明较高Qa水平会增加死亡风险,需要进一步研究来证实较低Qa时死亡风险增加。